Validity of model approximations for receptor-ligand kinetics in nuclear medicine.

about

Validity of model approximations for receptor-ligand kinetics in nuclear medicine.

Item

http://www.wikidata.org/entity/Q50985041

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Validity of model approximations for receptor-ligand kinetics in nuclear medicine.

@en

Validity of model approximations for receptor-ligand kinetics in nuclear medicine.

@nl

type

Item

label

Validity of model approximations for receptor-ligand kinetics in nuclear medicine.

@en

Validity of model approximations for receptor-ligand kinetics in nuclear medicine.

@nl

prefLabel

Validity of model approximations for receptor-ligand kinetics in nuclear medicine.

@en

Validity of model approximations for receptor-ligand kinetics in nuclear medicine.

@nl

P1476

Validity of model approximations for receptor-ligand kinetics in nuclear medicine

@en

P2093

Cristian A Salinas

http://www.w3.org/2001/XMLSchema#string

Raymond F Muzic

http://www.w3.org/2001/XMLSchema#string

P2860

A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography

Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET data.

Fundamentals of quantitative PET data analysis.

Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography.

Error analysis on parameter estimates in the ligand-receptor model: application to parameter imaging using PET data.

On the correction for radioactive decay in pharmacokinetic modeling.

Automated synthesis of the ultra high specific activity of [11C]Ro15-4513 and its application in an extremely low concentration region to an ARG study.

Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol.

Central D1- and D2-receptor occupancy during antipsychotic drug treatment.

Radiolabelling DOTA-peptides with 68Ga.

P304

1693-1703

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1118/1.2719569

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gerald M Saidel

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17555251

http://www.w3.org/2001/XMLSchema#string